Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cationic lipids with highly charged headgroups for efficient gene delivery.

Kai K Ewert1, Heather M Evans, Nathan F Bouxsein

  • 1Department of Materials, University of California, Santa Barbara, California 93106, USA. ewert@mrl.ucsb.edu

Bioconjugate Chemistry
|July 20, 2006
PubMed
Summary

New multivalent cationic lipids with dendritic headgroups improve nonviral gene therapy vectors. These novel cationic liposome-DNA complexes show efficient and non-toxic gene delivery to mammalian cells, enhancing therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of microtubule radial structure by competition between Tau and paclitaxel: Binding and x-ray scattering studies.

Biophysical journal·2025
Same author

A model of the microtubule cytoskeleton of the axon initial segment in mixtures of tubulin, tau, and GTP.

Biophysical journal·2025
Same author

Acidic Conditions Promote Clustering of Cancer Cell Derived Extracellular Vesicles and Enhance their Fusion with Synthetic Liposomes.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Mixtures of Intrinsically Disordered Neuronal Protein Tau and Anionic Liposomes Reveal Distinct Anionic Liposome-Tau Complexes Coexisting with Tau Liquid-Liquid Phase-Separated Coacervates.

Langmuir : the ACS journal of surfaces and colloids·2024
Same author

A Library of Custom PEG-Lipids reveals a Double-PEG-Lipid with Drastically Enhanced Paclitaxel Solubility and Human Cancer Cell Cytotoxicity when used in Fluid Micellar Nanoparticles.

bioRxiv : the preprint server for biology·2024
Same author

Mixtures of Intrinsically Disordered Neuronal Protein Tau and Anionic Liposomes Reveal Distinct Anionic Liposome-Tau Complexes Coexisting with Tau Liquid-Liquid Phase Separated Coacervates.

bioRxiv : the preprint server for biology·2024

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene therapy offers promising disease cures, but nonviral DNA delivery systems need improved efficiency and mechanistic understanding.
  • Current nonviral vectors face challenges with efficiency and incomplete mechanism elucidation.

Purpose of the Study:

  • To synthesize novel multivalent cationic lipids with dendritic headgroups for investigating structure-transfection efficiency relationships in cationic liposome-DNA complexes.
  • To develop improved nonviral vectors for gene therapy applications.

Main Methods:

  • Synthesis of dendritic lipids with varying positive charges (4-16) and ornithine/carboxyspermine endgroups.
  • Formation of cationic liposome (CL)-DNA complexes using dendritic lipids and neutral DOPC.

Related Experiment Videos

  • Analysis of complex structures (novel vs. lamellar phases) and their in vitro transfection efficiency in mammalian cells.

    • Main Results:

    • Novel structures formed in CL-DNA complexes at high dendritic lipid content, contrasting with lamellar phases at high DOPC content.
    • Efficient in vitro transfection of mammalian cells by DNA complexes of new dendritic lipids.
    • Demonstrated lack of cytotoxicity and sustained high transfection efficiency across a broad composition range.

    Conclusions:

    • Multivalent cationic lipids with dendritic headgroups represent a significant advancement in nonviral gene delivery systems.
    • These novel CL-DNA complexes offer a promising platform for efficient and safe gene therapy applications.
    • Understanding structure-activity relationships is key to optimizing nonviral vector performance.